Liu, X., Chen, X., Shi, L., Shan, Q., Cao, Q., Yue, C., . . . Yu, R. (2019). The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma. J Exp Clin Cancer Res.
シカゴスタイル引用形Liu, Xuejiao, et al. "The Third-generation EGFR Inhibitor AZD9291 Overcomes Primary Resistance By Continuously Blocking ERK Signaling in Glioblastoma." J Exp Clin Cancer Res 2019.
MLA引用形式Liu, Xuejiao, et al. "The Third-generation EGFR Inhibitor AZD9291 Overcomes Primary Resistance By Continuously Blocking ERK Signaling in Glioblastoma." J Exp Clin Cancer Res 2019.
警告: この引用は必ずしも正確ではありません.